sanofi glp-1 Asia-Pacific Glucagon-like Peptide-1 (GLP-1) Agonists Companies and intra Sanofi nabs long-sought FDA approval

Recombinant GLP-1R analogs with improved pharmacokinetics and sustained action are successful in the treatment of type-2 diabetes, and there is considerable and ongoing effort to further optimize their action profile to improve therapeutic outcome and patient compliance

Prevention is always better than treatment

The discovery that GLP-1 could regulate blood sugar without causing dangerous low-glucose episodes sparked decades of pharmaceutical research

doi: 10.1056/NEJMoa2307563 [DOI] [PubMed] [Google Scholar] 200

Think of it like a custom-tailored solution, perfectly fitted to your unique needs

Unfortunately, we dont know how many of Caremarks clients remained with a high-list-price product so as to maximize the value of their rebates